Pure red cell aplasia: Difference between revisions

Jump to navigation Jump to search
m (Robot: Changing Category:Disease state to Category:Disease)
m (Robot: Changing Category:Mature chapter to Category:Overview complete)
Line 42: Line 42:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Mature chapter]]
[[Category:Overview complete]]

Revision as of 18:23, 17 April 2012

Template:DiseaseDisorder infobox

WikiDoc Resources for Pure red cell aplasia

Articles

Most recent articles on Pure red cell aplasia

Most cited articles on Pure red cell aplasia

Review articles on Pure red cell aplasia

Articles on Pure red cell aplasia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pure red cell aplasia

Images of Pure red cell aplasia

Photos of Pure red cell aplasia

Podcasts & MP3s on Pure red cell aplasia

Videos on Pure red cell aplasia

Evidence Based Medicine

Cochrane Collaboration on Pure red cell aplasia

Bandolier on Pure red cell aplasia

TRIP on Pure red cell aplasia

Clinical Trials

Ongoing Trials on Pure red cell aplasia at Clinical Trials.gov

Trial results on Pure red cell aplasia

Clinical Trials on Pure red cell aplasia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pure red cell aplasia

NICE Guidance on Pure red cell aplasia

NHS PRODIGY Guidance

FDA on Pure red cell aplasia

CDC on Pure red cell aplasia

Books

Books on Pure red cell aplasia

News

Pure red cell aplasia in the news

Be alerted to news on Pure red cell aplasia

News trends on Pure red cell aplasia

Commentary

Blogs on Pure red cell aplasia

Definitions

Definitions of Pure red cell aplasia

Patient Resources / Community

Patient resources on Pure red cell aplasia

Discussion groups on Pure red cell aplasia

Patient Handouts on Pure red cell aplasia

Directions to Hospitals Treating Pure red cell aplasia

Risk calculators and risk factors for Pure red cell aplasia

Healthcare Provider Resources

Symptoms of Pure red cell aplasia

Causes & Risk Factors for Pure red cell aplasia

Diagnostic studies for Pure red cell aplasia

Treatment of Pure red cell aplasia

Continuing Medical Education (CME)

CME Programs on Pure red cell aplasia

International

Pure red cell aplasia en Espanol

Pure red cell aplasia en Francais

Business

Pure red cell aplasia in the Marketplace

Patents on Pure red cell aplasia

Experimental / Informatics

List of terms related to Pure red cell aplasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Acquired pure red cell aplasia (or PRCA) refers to a type of anemia affecting the precursors to red blood cells but not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells.

Causes

Pure red cell aplasia is regarded as an autoimmune disease. It may also be a manifestation of thymoma. It may also be as a result of viral infections such as HIV, herpes, parvovirus B19 (Fifth disease), or hepatitis. Association of pure red cell aplasia with T large granular lymphocyte leukemia is also well recognized, especially in China (http://jcp.bmj.com/cgi/content/abstract/51/9/672). Many cases of PRCA are considered idiopathic in that there is no discernable cause detected.

It can be associated with the administration of erythropoietin.

Treatment

PRCA is considered an autoimmune disease as it will respond to immunosuppressant treatment such as ciclosporin. It has also been also been shown to respond to treatments with Rituxan.

See also

External links

Template:Hematology

Template:WikiDoc Sources